每周股票复盘：易明医药（002826）控制权变更，股价异动上榜

Group 1 - Yiming Pharmaceutical (002826) closed at 16.21 yuan on June 6, 2025, a 33.09% increase from the previous week's 12.18 yuan, reaching a near one-year high [1] - The company's total market capitalization is currently 3.091 billion yuan, ranking 127th out of 150 in the chemical pharmaceutical sector and 4141st out of 5148 in the A-share market [1] - The stock was listed on the "Dragon and Tiger List" for the first time in five trading days due to a cumulative price deviation of 20% over three consecutive trading days [1][3] Group 2 - The company announced that its controlling shareholder, Gao Fan, plans to transfer 23% of his shares (43,855,883 shares) to Beijing Fuhai at a price of 15.10 yuan per share, totaling approximately 662.22 million yuan [1] - Following this equity change, the controlling shareholder will shift from Gao Fan to Beijing Fuhai, with the actual controller changing to Yao Jinbo [1][3] - Yiming Pharmaceutical's wholly-owned subsidiary, Sichuan Weiao Pharmaceutical Co., Ltd., received a government subsidy of 4.853 million yuan, which is expected to increase the company's total profit for 2025 by the same amount [2][3]